Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
批准号:
10438878
负责人:
Christopher F Basler
金额:
$21.75万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-01 至 2023-06-30
关键词:
2-5A Synthetase2019-nCoVAffectAffinityBindingBinding SitesBiological AssayBypassC-terminalCOVID-19 pandemicCell NucleusChiropteraComplexCoronavirus InfectionsCrystallizationCytoplasmDangerousnessDataEnzymesExhibitsGenetic PolymorphismGenetic TranscriptionHumanIRF3 geneImmuneImmune EvasionImmune responseImmune signalingImmunoprecipitationImpairmentInfectionInterferon-betaInterferonsInvestigationLengthLigaseMeasuresMediatingMerbecovirusMiddle East Respiratory SyndromeMiddle East Respiratory Syndrome CoronavirusModelingMusMutagenesisMutationN-terminalNatural ImmunityNuclearNuclear ImportNuclear Localization SignalNuclear ProteinNuclear ReceptorsNuclear TranslocationPathogenesisPathogenicityPathway interactionsPeptide Signal SequencesPersonsPlayPositioning AttributeProductionProtein ImportProtein IsoformsProteinsRNA VirusesReportingRibonucleasesRoleSARS coronavirusSTAT1 geneSignal TransductionSiteSpecificityStructureTNFRSF5 geneTestingTherapeutic InterventionTransfectionVariantViralViral ProteinsVirulenceVirusVirus DiseasesVirus ReplicationX-Ray CrystallographyZoonosesalpha Karyopherinsbasebetacoronaviruscytokineimprovedinhibitorinnate immune pathwaysmutantnovel coronavirusoligoadenylatep65pathogenphosphoric diester hydrolasepreferencepreventprotein functionresponsestructural biologytherapeutic developmenttranscription factorzoonotic coronavirus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Middle East respiratory syndrome coronavirus (MERS-CoV), is a highly pathogenic, zoonotic, non-segmented, positive-sense RNA virus related to the severe acute respiratory syndrome coronavirus (SARS CoV) and SARS-CoV-2 that can spread from person to person. The potential threat posed by zoonotic coronaviruses is demonstrated by the emergence of SARS-CoV-2 and the subsequent COVID-19 pandemic. Because MERS CoV remains a threat, an understanding of mechanisms of MERS CoV replication, particularly as these related to pathogenesis and therapeutic development, remains critical. ORF4b (4b) is notable among the MERS CoV accessory proteins because it strongly localizes to the nucleus, despite virus replication occurring in the cytoplasm, and it exerts innate immune evasion functions. These include inhibition of interferon beta (IFNβ) and IFNλ production and inhibition of NF-κB-dependent cytokine production. The 4b protein also inhibits the 2’, 5’ oligoadenylate synthetase (OAS)-RNase L pathway, an activity attributed to its C-terminal phosphodiesterase domain. ORF4b is a nuclear protein and both transfection- and infection-based assays indicate that mutation of the apparent ORF4b nuclear localization signal (NLS) impairs affects inhibition of innate immune evasion functions. One notable study found that 4b blocks NF-ĸB-dependent responses and this correlated with the capacity of 4b to outcompete the p65 subunit of NF-ĸB for IMPA3 binding. We have undertaken X ray crystallography studies of the 4b-IMPA interaction. Our Preliminary Data demonstrate that 4b has uniquely bypassed canonical rules of NLS recognition and does not contain a Lys residue at a binding site formerly thought to be critical for NLS function. Further, the proposed specificity of 4b for IMPA3 is not fully supported by our data. We found that the NLS region of 4b binds IMPA2 and with an interface that is more extensive than IMPA3. Thus, the specificity that has been proposed is unlikely to be mediated by this simple interaction interface. Furthermore, if 4b is able to bind a greater range of IMPA isoforms than had previously been proposed, this MERS-CoV protein is likely to be able to competitively inhibit the nuclear import of other innate immune transcription factors such as IRF3 and STAT1. Consistent with such a model, Preliminary Data of crystal structures of the p50 NF-κB NLS bound to IMPA2 and IMPA3 demonstrate that these regions overlap with MERS ORF4b. Based on these observations, we propose to solve structures of full-length and NLS peptides of MERS- CoV and bat Merbecovirus ORF4b proteins in complex with nuclear receptor IMPA isoforms and define interaction interfaces. .This will provide a structural basis for the specificity of ORF4b binding and nuclear import. To compare the structural data obtained for ORF4b and IMPAs, we will determine the structures of IMPA isoforms in complex with NF-κB to establish a structural basis for the immune evasion. Finally. we will test the hypothesis that ORF4b inhibits NF-κB signaling and IFN production by competing for p50-IMPA interaction in transfection-based and virus infection studies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41467-022-28851-2
发表时间:
2022-03-25
期刊:
Nature communications
影响因子:
16.6
作者:
[Munasinghe TS, Edwards MR, Tsimbalyuk S, Vogel OA, Smith KM, Stewart M, Foster JK, Bosence LA, Aragão D, Roby JA, Basler CF, Forwood JK]
通讯作者:
Forwood JK
Inhibitors of SARS-CoV-2 Polymerase
-
批准号:10514325
-
项目类别:
-
资助金额:$435.32万
-
财政年份:2022
-
负责人:Christopher F Basler
-
依托单位:
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
-
批准号:10289173
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2021
-
负责人:Christopher F Basler
-
依托单位:
VPS34 inhibitors as SARS-CoV-2 antivirals
-
批准号:10534720
-
项目类别:
-
资助金额:$41.59万
-
财政年份:2021
-
负责人:Christopher F Basler
-
依托单位:
Small Molecule Inhibitors of Ebola Virus Polymerase Function
-
批准号:10534719
-
项目类别:
-
资助金额:$77.03万
-
财政年份:2021
-
负责人:Christopher F Basler
-
依托单位:
Understanding how the MERS Coronavirus protein ORF4b interactions with importin alpha modulate innate immunity
-
批准号:10536332
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2021
-
负责人:Christopher F Basler
-
依托单位:
VPS34 inhibitors as SARS-CoV-2 antivirals
-
批准号:10238577
-
项目类别:
-
资助金额:$1.31万
-
财政年份:2021
-
负责人:Christopher F Basler
-
依托单位:
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
-
批准号:10593400
-
项目类别:
-
资助金额:$40.76万
-
财政年份:2020
-
负责人:Christopher F Basler
-
依托单位:
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
-
批准号:10425317
-
项目类别:
-
资助金额:$61.95万
-
财政年份:2020
-
负责人:Christopher F Basler
-
依托单位:
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
-
批准号:10214516
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2020
-
负责人:Christopher F Basler
-
依托单位:
Intersection Between Viral Translation and Innate Immunity in the Context of Filovirus Infection
-
批准号:10665712
-
项目类别:
-
资助金额:$61.95万
-
财政年份:2020
-
负责人:Christopher F Basler
-
依托单位:
Small Molecule Inhibitors of Ebola Virus Polymerase Function
-
批准号:9311467
-
项目类别:
-
资助金额:$91.84万
-
财政年份:2017
-
负责人:Christopher F Basler
-
依托单位:
Small Molecule Inhibitors of Ebola Virus Polymerase Function
-
批准号:9433610
-
项目类别:
-
资助金额:$87.29万
-
财政年份:2017
-
负责人:Christopher F Basler
-
依托单位:
Small Molecule Inhibitors of Ebola Virus Polymerase Function
-
批准号:10088374
-
项目类别:
-
资助金额:$18.09万
-
财政年份:2017
-
负责人:Christopher F Basler
-
依托单位:
Molecular mechanisms of immune dysregulation by filoviral interferon
-
批准号:9001893
-
项目类别:
-
资助金额:$67.11万
-
财政年份:2016
-
负责人:Christopher F Basler
-
依托单位:
Contributions of Ebola and Marburg virus VP30 and VP24 proteins to viral RNA synthesis, assembly and egress
-
批准号:10555056
-
项目类别:
-
资助金额:$43.64万
-
财政年份:2016
-
负责人:Christopher F Basler
-
依托单位:
Administrative Core
-
批准号:9001896
-
项目类别:
-
资助金额:$9.24万
-
财政年份:2016
-
负责人:Christopher F Basler
-
依托单位:
High-throughput screen for inhibitors of Marburg virus VP24-Keap1
-
批准号:8964015
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2015
-
负责人:Christopher F Basler
-
依托单位:
High-throughput screen for inhibitors of Marburg virus VP24-Keap 1
-
批准号:9284170
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2015
-
负责人:Christopher F Basler
-
依托单位:
Mechanisms of evasion of the innate and adaptive immune responses to filoviruses
-
批准号:9245827
-
项目类别:
-
资助金额:$190.46万
-
财政年份:2014
-
负责人:Christopher F Basler
-
依托单位:
Mechanisms of evasion of the innate and adaptive immune responses to filoviruses
-
批准号:9212085
-
项目类别:
-
资助金额:$186.14万
-
财政年份:2014
-
负责人:Christopher F Basler
-
依托单位:
国内基金
海外基金
登录
查看更多内容
微米和纳米塑料作用下2019-nCoV抗病毒药物利巴韦林对河蚬的毒性作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:郭晓宇
-
依托单位:
2019-nCoV感染导致人体淋巴细胞减低机制及其对机体免疫功能影响
-
批准号:82030002
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:曹彬
-
依托单位:
基于人口流动大数据的新型冠状病毒(2019-nCoV)输出感染风险及接触网络传播模型研究
-
批准号:--
-
项目类别:--
-
资助金额:135万元
-
批准年份:2020
-
负责人:吕欣
-
依托单位:
云南驯养野生动物中新型冠状病毒(2019-nCoV)溯源调查与验证
-
批准号:--
-
项目类别:--
-
资助金额:140万元
-
批准年份:2020
-
负责人:夏雪山
-
依托单位:
新型冠状病毒(2019-nCoV)反向遗传系统及啮齿类感染模型的建立与应用
-
批准号:--
-
项目类别:--
-
资助金额:150万元
-
批准年份:2020
-
负责人:黄耀伟
-
依托单位:
血必净预防2019-nCoV肺炎发生ARDS及机制研究
-
批准号:82041003
-
项目类别:专项基金项目
-
资助金额:135万元
-
批准年份:2020
-
负责人:宋元林
-
依托单位:
新型冠状病毒2019-nCoV复制复合体关键蛋白的功能与潜在药物靶点研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:郭德银
-
依托单位:
人新型冠状病毒2019-nCoV受体利用介导的种间传播和感染机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:140万元
-
批准年份:2020
-
负责人:葛行义
-
依托单位:
2019-nCoV蝙蝠及人群代表性流行株致病能力的比较研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:周鹏
-
依托单位:
新型冠状病毒2019-nCoV重要复制加帽酶的工作机制研究
-
批准号:--
-
项目类别:专项基金项目
-
资助金额:150万元
-
批准年份:2020
-
负责人:陈宇
-
依托单位: